# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5251097 | B | Inhibition of human full length USP21 using Btn-Ahx-PNIRFLD-K(Ubi)-LPQQT-GD-amide as substrate preincubated for 15 to 20 mins followed by substrate addition and measured after 25 mins by HTRF assay | Homo sapiens | 22 | single protein format | Scientific Literature | ||
2. | ALA5251098 | B | Inhibition of human USP21 using ubiquitin rhodamine 110 110 as substrate preincubated for 15 to 20 mins followed by enzyme addition and measured after 25 mins by fluorometric assay | Homo sapiens | 22 | single protein format | Scientific Literature | ||
3. | ALA5251115 | P | Lipophilicity, logD of compound at pH 7.5 by HPCL analysis | 22 | small-molecule physicochemical format | Scientific Literature | |||
4. | ALA5251116 | P | Aqueous solubility of compound in PBS at pH 6.5 incubated for 24 hrs by HPLC-MS/MS analysis | 12 | small-molecule physicochemical format | Scientific Literature | |||
5. | ALA5251117 | B | Inhibition of human full length USP21 using Btn-Ahx-PNIRFLD-K(Ubi)-LPQQT-GD-amide as substrate assessed as maximal response preincubated for 15 to 20 mins followed by substrate addition and measured after 25 mins by HTRF assay | Homo sapiens | 11 | single protein format | Scientific Literature | ||
6. | ALA5251118 | B | Inhibition of human USP21 using ubiquitin rhodamine 110 as substrate assessed as maximal response preincubated for 15 to 20 mins followed by enzyme addition and measured after 25 mins by fluorometric assay | Homo sapiens | 8 | single protein format | Scientific Literature |